|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 114, Issue 5 853-865, Copyright © 2001 by Company of Biologists
JOURNAL ARTICLES |
CJ Robinson and SE Stringer
The Cancer Research Campaign Department of Drug Development and the CRC and University of Manchester Department of Medical Oncology, Paterson Institute for Cancer Research, Christie Hospital, Manchester, M20 4BX, UK.
Vascular endothelial growth factor (VEGF) is a secreted mitogen highly specific for cultured endothelial cells. In vivo VEGF induces microvascular permeability and plays a central role in both angiogenesis and vasculogenesis. VEGF is a promising target for therapeutic intervention in certain pathological conditions that are angiogenesis dependent, most notably the neovascularisation of growing tumours. Through alternative mRNA splicing, a single gene gives rise to several distinct isoforms of VEGF, which differ in their expression patterns as well as their biochemical and biological properties. Two VEGF receptor tyrosine kinases (VEGFRs) have been identified, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). VEGFR-2 seems to mediate almost all observed endothelial cell responses to VEGF, whereas roles for VEGFR-1 are more elusive. VEGFR-1 might act predominantly as a ligand-binding molecule, sequestering VEGF from VEGFR-2 signalling. Several isoform-specific VEGF receptors exist that modulate VEGF activity. Neuropilin-1 acts as a co-receptor for VEGF(165), enhancing its binding to VEGFR-2 and its bioactivity. Heparan sulphate proteoglycans (HSPGs), as well as binding certain VEGF isoforms, interact with both VEGFR-1 and VEGFR-2. HSPGs have a wide variety of functions, such as the ability to partially restore lost function to damaged VEGF(165) and thereby prolonging its biological activity.
This article has been cited by other articles:
|
|
 |
|
  C. Q. Yu, M. Zhang, K. I. Matis, C. Kim, and M. I. Rosenblatt Vascular Endothelial Growth Factor Mediates Corneal Nerve Repair Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3870 - 3878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Criswell, W.-Z. Hu, T. J. Steffens, R. Li, and P. Margaron Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model Arch Ophthalmol, July 1, 2008; 126(7): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Dickinson, B. K. Sturges, R. J. Higgins, B. N. Roberts, C. M. Leutenegger, A. W. Bollen, and R. A. LeCouteur Vascular Endothelial Growth Factor mRNA Expression and Peritumoral Edema in Canine Primary Central Nervous System Tumors Vet. Pathol., March 1, 2008; 45(2): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Bryan, T. E. Walshe, D. C. Mitchell, J. S. Havumaki, M. Saint-Geniez, A. S. Maharaj, A. E. Maldonado, and P. A. D'Amore Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation Mol. Biol. Cell, March 1, 2008; 19(3): 994 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sivakumar, N. Sharma-Walia, H. Raghu, M. V. Veettil, S. Sadagopan, V. Bottero, L. Varga, R. Levine, and B. Chandran Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications J. Virol., February 15, 2008; 82(4): 1759 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mineur, A. C. Colige, Christophe. F. Deroanne, J. Dubail, F. Kesteloot, Y. Habraken, A. Noel, S. Voo, J. Waltenberger, C. M. Lapiere, et al. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents J. Cell Biol., December 17, 2007; 179(6): 1261 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Thomas, J. I. Andrews, and K. Z. Liu Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta FASEB J, December 1, 2007; 21(14): 3885 - 3895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Ji, F. Mac Gabhann, and A. S. Popel Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3740 - H3749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bahary, K. Goishi, C. Stuckenholz, G. Weber, J. LeBlanc, C. A. Schafer, S. S. Berman, M. Klagsbrun, and L. I. Zon Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish Blood, November 15, 2007; 110(10): 3627 - 3636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fischer, T. Gerriets, C. Wessels, M. Walberer, S. Kostin, E. Stolz, K. Zheleva, A. Hocke, S. Hippenstiel, and K. T. Preissner Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor Blood, October 1, 2007; 110(7): 2457 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain J. Biol. Chem., September 21, 2007; 282(38): 28045 - 28056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zygalaki, E. G. Tsaroucha, L. Kaklamanis, and E. S. Lianidou Quantitative Real-Time Reverse Transcription PCR Study of the Expression of Vascular Endothelial Growth Factor (VEGF) Splice Variants and VEGF Receptors (VEGFR-1 and VEGFR-2) in Non Small Cell Lung Cancer Clin. Chem., August 1, 2007; 53(8): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Springer, A. Banfi, J. Ye, G. von Degenfeld, P. E. Kraft, S. A. Saini, N. K. Kapasi, and H. M. Blau Localization of vascular response to VEGF is not dependent on heparin binding FASEB J, July 1, 2007; 21(9): 2074 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Harant, B. Wolff, E. P. Schreiner, B. Oberhauser, L. Hofer, N. Lettner, S. Maier, J. E. de Vries, and I. J. Lindley Inhibition of Vascular Endothelial Growth Factor Cotranslational Translocation by the Cyclopeptolide CAM741 Mol. Pharmacol., June 1, 2007; 71(6): 1657 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wilkinson, T. Gilbert, G. Kinna, L.-A. Ruta, D. Pennisi, M. Kett, and M. H. Little Crim1KST264/KST264 Mice Implicate Crim1 in the Regulation of Vascular Endothelial Growth Factor-A Activity during Glomerular Vascular Development J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1697 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V L Bosquiazzo, J G Ramos, J Varayoud, M Munoz-de-Toro, and E H Luque Mast cell degranulation in rat uterine cervix during pregnancy correlates with expression of vascular endothelial growth factor mRNA and angiogenesis Reproduction, May 1, 2007; 133(5): 1045 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kong, Y. Li, Z. Wang, S. Banerjee, and F. H. Sarkar Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-{kappa}B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer Cancer Res., April 1, 2007; 67(7): 3310 - 3319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, S. Hazarika, D. Xie, A. M. Pippen, C. D. Kontos, and B. H. Annex In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor (VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces Therapeutic Angiogenesis After Hindlimb Ischemia Diabetes, March 1, 2007; 56(3): 656 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mac Gabhann, J. W. Ji, and A. S. Popel VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle J Appl Physiol, February 1, 2007; 102(2): 722 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gampel, L. Moss, M. C. Jones, V. Brunton, J. C. Norman, and H. Mellor VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment Blood, October 15, 2006; 108(8): 2624 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shchors, E. Shchors, F. Rostker, E. R. Lawlor, L. Brown-Swigart, and G. I. Evan The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta Genes & Dev., September 15, 2006; 20(18): 2527 - 2538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Bourlev, N Volkov, S Pavlovitch, N Lets, A Larsson, and M Olovsson The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction, September 1, 2006; 132(3): 501 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Holloway, A. W. Beck, L. Shivakumar, J. Shih, J. B. Fleming, and R. A. Brekken Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts Ann. Surg. Oncol., August 1, 2006; 13(8): 1145 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pieren, A. E. Prota, C. Ruch, D. Kostrewa, A. Wagner, K. Biedermann, F. K. Winkler, and K. Ballmer-Hofer Crystal Structure of the Orf Virus NZ2 Variant of Vascular Endothelial Growth Factor-E: IMPLICATIONS FOR RECEPTOR SPECIFICITY J. Biol. Chem., July 14, 2006; 281(28): 19578 - 19587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Karpanen, C. A. Heckman, S. Keskitalo, M. Jeltsch, H. Ollila, G. Neufeld, L. Tamagnone, and K. Alitalo Functional interaction of VEGF-C and VEGF-D with neuropilin receptors FASEB J, July 1, 2006; 20(9): 1462 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R L Medford and A B Millar Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax, July 1, 2006; 61(7): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tropea, F. Miceli, F. Minici, F. Tiberi, M. Orlando, M. F. Gangale, F. Romani, S. Catino, S. Mancuso, P. Navarra, et al. Regulation of Vascular Endothelial Growth Factor Synthesis and Release by Human Luteal Cells in Vitro J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2303 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ding, J. Li, J. Chen, H. Chen, W. Ouyang, R. Zhang, C. Xue, D. Zhang, S. Amin, D. Desai, et al. Effects of Polycyclic Aromatic Hydrocarbons (PAHs) on Vascular Endothelial Growth Factor Induction through Phosphatidylinositol 3-Kinase/AP-1-dependent, HIF-1{alpha}-independent Pathway J. Biol. Chem., April 7, 2006; 281(14): 9093 - 9100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Eremina, S. Cui, H. Gerber, N. Ferrara, J. Haigh, A. Nagy, M. Ema, J. Rossant, S. Jothy, J. H. Miner, et al. Vascular Endothelial Growth Factor A Signaling in the Podocyte-Endothelial Compartment Is Required for Mesangial Cell Migration and Survival J. Am. Soc. Nephrol., March 1, 2006; 17(3): 724 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Martelli, P Berardinelli, V Russo, A Mauro, N Bernabo, L Gioia, M Mattioli, and B Barboni Spatio-temporal analysis of vascular endothelial growth factor expression and blood vessel remodelling in pig ovarian follicles during the periovulatory period J. Mol. Endocrinol., February 1, 2006; 36(1): 107 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Robinson, B. Mulloy, J. T. Gallagher, and S. E. Stringer VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase J. Biol. Chem., January 20, 2006; 281(3): 1731 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Pradeep, E. S. Sunila, and G. Kuttan Expression of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptors in Tumor Angiogenesis and Malignancies Integr Cancer Ther, December 1, 2005; 4(4): 315 - 321. [Abstract] [PDF]
|
|
|
|
|
|
A. El-Sheikh, P. Borgstrom, G. Bhattacharjee, M. Belting, and T. S. Edgington A Selective Tumor Microvasculature Thrombogen that Targets a Novel Receptor Complex in the Tumor Angiogenic Microenvironment Cancer Res., December 1, 2005; 65(23): 11109 - 11117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tesone, R. L. Stouffer, S. M. Borman, J. D. Hennebold, and T. A. Molskness Vascular Endothelial Growth Factor (VEGF) Production by the Monkey Corpus Luteum During the Menstrual Cycle: Isoform-Selective Messenger RNA Expression In Vivo and Hypoxia-Regulated Protein Secretion In Vitro Biol Reprod, November 1, 2005; 73(5): 927 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Niida, T. Kondo, S. Hiratsuka, S.-I. Hayashi, N. Amizuka, T. Noda, K. Ikeda, and M. Shibuya VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice PNAS, September 27, 2005; 102(39): 14016 - 14021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ashikari-Hada, H. Habuchi, Y. Kariya, and K. Kimata Heparin Regulates Vascular Endothelial Growth Factor165-dependent Mitogenic Activity, Tube Formation, and Its Receptor Phosphorylation of Human Endothelial Cells: COMPARISON OF THE EFFECTS OF HEPARIN AND MODIFIED HEPARINS J. Biol. Chem., September 9, 2005; 280(36): 31508 - 31515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Thaker, S. Yazici, M. B. Nilsson, K. Yokoi, R. Z. Tsan, J. He, S.-J. Kim, I. J. Fidler, and A. K. Sood Antivascular Therapy for Orthotopic Human Ovarian Carcinoma through Blockade of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptors Clin. Cancer Res., July 1, 2005; 11(13): 4923 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. McCullough, C. R. Cantor, and C. Ding High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Nucleic Acids Res., June 20, 2005; 33(11): e99 - e99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lee, S. M. Jilani, G. V. Nikolova, D. Carpizo, and M. L. Iruela-Arispe Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors J. Cell Biol., May 23, 2005; 169(4): 681 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wei, M. Lyon, and J. T. Gallagher Distinct Substrate Specificities of Bacterial Heparinases against N-Unsubstituted Glucosamine Residues in Heparan Sulfate J. Biol. Chem., April 22, 2005; 280(16): 15742 - 15748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. van Wijngaarden, D. J. Coster, and K. A. Williams Inhibitors of Ocular Neovascularization: Promises and Potential Problems JAMA, March 23, 2005; 293(12): 1509 - 1513. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res, February 15, 2005; 65(3): 550 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gaudreault, D. Fei, J. Rusit, P. Suboc, and V. Shiu Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 726 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G D Perkins, J Roberts, D F McAuley, L Armstrong, A Millar, F Gao, and D R Thickett Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury Thorax, February 1, 2005; 60(2): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, E. Kilic, U. Kilic, B. Weber, C. L. Bassetti, H. H. Marti, and D. M. Hermann VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena Brain, January 1, 2005; 128(1): 52 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Abdel-Rahman, E. L. Craig, F. H. Davidorf, and C. Eng Expression of Vascular Endothelial Growth Factor in Uveal Melanoma Is Independent of 6p21-Region Copy Number Clin. Cancer Res., January 1, 2005; 11(1): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Dikov, J. E. Ohm, N. Ray, E. E. Tchekneva, J. Burlison, D. Moghanaki, S. Nadaf, and D. P. Carbone Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation J. Immunol., January 1, 2005; 174(1): 215 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.N. Mowa, S. Jesmin, I. Sakuma, S. Usip, H. Togashi, M. Yoshioka, Y. Hattori, and R. Papka Characterization of Vascular Endothelial Growth Factor (VEGF) in the Uterine Cervix over Pregnancy: Effects of Denervation and Implications for Cervical Ripening J. Histochem. Cytochem., December 1, 2004; 52(12): 1665 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mura, C. C. dos Santos, D. Stewart, and M. Liu Vascular endothelial growth factor and related molecules in acute lung injury J Appl Physiol, November 1, 2004; 97(5): 1605 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nagamatsu, T. Fujii, M. Kusumi, L. Zou, T. Yamashita, Y. Osuga, M. Momoeda, S. Kozuma, and Y. Taketani Cytotrophoblasts Up-Regulate Soluble Fms-Like Tyrosine Kinase-1 Expression under Reduced Oxygen: An Implication for the Placental Vascular Development and the Pathophysiology of Preeclampsia Endocrinology, November 1, 2004; 145(11): 4838 - 4845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takahashi, S. Hattori, A. Iwamatsu, H. Takizawa, and M. Shibuya A Novel Snake Venom Vascular Endothelial Growth Factor (VEGF) Predominantly Induces Vascular Permeability through Preferential Signaling via VEGF Receptor-1 J. Biol. Chem., October 29, 2004; 279(44): 46304 - 46314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Dai, J. Huang, B. Klitzman, C. Dong, P. J. Goldschmidt-Clermont, K. L. March, J. Rokovich, B. Johnstone, E. J. Rebar, S. K. Spratt, et al. Engineered Zinc Finger-Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb Ischemia Circulation, October 19, 2004; 110(16): 2467 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-H. Zhou, M. Yao, T.-S. Lee, Y. Zhu, M. Martins-Green, and J. Y.-J. Shyy Vascular Endothelial Growth Factor Activation of Sterol Regulatory Element Binding Protein: A Potential Role in Angiogenesis Circ. Res., September 3, 2004; 95(5): 471 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Levine and D. Teegarden 1{alpha},25-Dihydroxycholecalciferol Increases the Expression of Vascular Endothelial Growth Factor in C3H10T1/2 Mouse Embryo Fibroblasts J. Nutr., September 1, 2004; 134(9): 2244 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, J. H. Kwak, S. I. Kim, Y. He, and M. E. Choi Transforming Growth Factor-{beta}1 Stimulates Vascular Endothelial Growth Factor 164 via Mitogen-activated Protein Kinase Kinase 3-p38{alpha} and p38{delta} Mitogen-activated Protein Kinase-dependent Pathway in Murine Mesangial Cells J. Biol. Chem., August 6, 2004; 279(32): 33213 - 33219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Lieto and N. L. Thompson Total Internal Reflection with Fluorescence Correlation Spectroscopy: Nonfluorescent Competitors Biophys. J., August 1, 2004; 87(2): 1268 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Davies, F. H. Blackhall, J. H. Shanks, G. David, A. T. McGown, R. Swindell, R. J. Slade, P. Martin-Hirsch, J. T. Gallagher, and G. C. Jayson Distribution and Clinical Significance of Heparan Sulfate Proteoglycans in Ovarian Cancer Clin. Cancer Res., August 1, 2004; 10(15): 5178 - 5186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lundkvist, A. Reichenbach, C. Betsholtz, P. Carmeliet, H. Wolburg, and M. Pekny Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences J. Cell Sci., July 15, 2004; 117(16): 3481 - 3488. [Abstract] [Full Text] [PDF]
|
|
